2016 International Congress

Tuesday, June 21, 2016

12:30pm-2:00pm

Bcr-Abl tyrosine-kinase inhibitors (B-ATKI) and Parkinson’s disease (PD)

E.A. Shamim, S.F. Baker, F.F. Liu, K.K. Mane, J.G. Layug, S. Vupputuri, C.C. DiStasio, S.M. Khandhar, C. Neff, S. Van Den Eeden, C. Lungu, R. Cooley, H.S. Martel, C. Chen, J. Dorman, M.A. Sinkiewicz, J. Klingman (Largo, MD, USA)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Beyond initial clinical phenotype of Madelung disease: Myoclonus, gait disorder and multisystem involvement led to genetic diagnosis

R. López-Blanco, A. Rojo-Sebastián, M.H. Torregrosa-Martínez, M. Molina-Sánchez, A. Blázquez-Encinar, M.Á. Martín-Casanueva (Madrid, Spain)

Myoclonus  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Bi-hemispheric phase synchronization in patients with Parkinson’s disease during stance, gait and upper limb motor tasks

M. Plotnik, Y. Miron, S. Hassin-Baer, O.S. Cohen, S. Kimel-Naor, I. Blatt, R. Inzelberg, J.W. Kantelhardt (Tel Hashomer, Israel)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Brain metabolic profile changes reflect subtle pathological alterations in different murine models of Parkinson’s disease

E. Glaab, F. Giesert, C. Jaeger, P. Dirscherl, A. Zimprich, A. Ulusoy, D.A. Di Monte, P. Garcia, R. Balling, W. Wurst, D. Truembach, M. Buttini, D. Vogt-Weisenhorn (Esch-Alzette, Luxembourg)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Bristle hair may point to hereditary spastic paraplegia type SPG35/ FAHN

T.W. Rattay, A.S. Söhn, K.N. Karle, S. Wiethoff, J. Reichbauer, M. Döbler-Neumann, I. Krägeloh-Mann, A. Münchau, B. Wilken, P. Bauer, L. Schöls, R. Schüle (Tübingen, Germany)

Rare genetic and metabolic diseases  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

C9ORF72 intermediate repeat copies as a rare genetic cause of atypical Parkinsonian syndromes or Parkinson’s disease complicated by psychosis in a Sardinian population

M. Meloni, A. Cannas, P. Solla, M.M. Mascia, G. Orofino, R. Farris, D. Ciaccio, E. Binaghi, M.R. Murru, F. Marrosu (Cagliari, Italy)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Can body worn cameras help us understand the complex relationship between physical activity and falls in people with Parkinson’s?

K. Baker, M. Harvey, J. Monaghan, L. Rochester (Newcastle Upon Tyne, United Kingdom)

Technology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Caring for the majority: Telemedicine management of Parkinson’s disease (PD) in underserved populations in People’s Republic of China: A randomized trial

P.B. Chan, S. Liu, Z. Gu, J. An, C.M. Tanner (Beijing, People's Republic of China)

Technology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Carrier mediated delivery system bearing dopamine for effective management of parkinsonism

V. Bhargava, S. Bhargava (Kanpur, India)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Cell-surface expression of dopamine transporter facilitates the uptake of α-synuclein

J. Kobayashi, T. Hasegawa, S. Yoshida, N. Sugeno, R. Oshima, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2